Extensive research over the past decade has provided evidence that GLP-1 receptor agonists do not appear to increase the risk of pancreatic cancer
A: It is typically taken in the morning before meals for appetite support
Download Shotsy for free from the App Store or Google Play
This infographic breaks down these drugs by active ingredients, brand names and approved uses of popular GLP-1s
What is the expected demand growth for GLP-1 receptor agonists between 2026 and 2036
Data analysed by one-way ANOVA, multiple comparison, Bonferroni post hoc test ( f , g , j , l - n , r and s ), two-way repeated measures ANOVA to assess main effects of treatment ( b , c , e and k ), and ANCOVA computed with calR using body weight as a covariate ( p )